VAERS reports by lot

GSK Flu lot 5GC54: VAERS reports

46 VAERS reports list lot 5GC54 as a GSK Flu vaccine, received between 2017-08-11 and 2018-02-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
46
Reports
4%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4330%
General / Systemic (non-local)2417%
Dermatological (non-injection-site)1410%
Neurological139%
Musculoskeletal128%
Allergic / Anaphylactic118%
Gastrointestinal107%
Cardiac / Cardiovascular75%
Thrombotic / Hematological43%
Respiratory32%
Psychiatric / Neuropsychiatric32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
Alabama4
Maine4
Florida3
New York3
Georgia2
Pennsylvania2
Ohio2
Michigan2
Virginia2
Nevada1
Maryland1

Reports by month received

2017-088
2017-0920
2017-109
2017-115
2017-123
2018-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.